Skip to the page

Data / Form D filings / Synapticure, Inc.

Synapticure, Inc.: Form D filing

Synapticure, Inc., a health care company in Chicago, IL, filed a Form D with the SEC in 2024. The latest, on September 24, 2024, reports $40.1 million sold of a $40.1 million offering to 51 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2045 W. Grand Ave, Suite B, Chicago, IL, 60612
Phone
(202) 468-6893
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2038193

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 24, 2024New notice$40,145,500$40,145,50051Sep 9, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sandra AbrevayaExecutive Officer, Director
Adam SeabrookDirector
Brian WallachDirector
Peter WallachExecutive Officer
Joe LeinbachExecutive Officer
Jason LangheierDirector
Eric AndersonExecutive Officer

Other health care companies in Illinois that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in Illinois · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Synapticure, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.